Life Sciences

Insights brief: Advancing outcomes-based contracting

Share this post:

The shift from volume to value in health care has presented life sciences companies with tremendous challenges and opportunities to proactively manage cost pressure and scientific innovation.

 

Truven Health Analytics®, an IBM Watson Health™ business, held discussions with more than a dozen life sciences companies to gather in-depth insights on their experience and intentions for outcomes-based contracts (OBCs). Viewed as an innovative way to improve patients’ access to the right therapies, life sciences companies are facing strategic and tactical challenges implementing OBCs.

 

In this brief, we share insights on the challenges in managing outcomes-based contracts (OBCs) with health plans today and solutions to address these challenges, based on our conversations with life sciences companies.

 

More Life Sciences Stories

IBM Explorys Offerings for Life Sciences: Cohort Analysis

Written by Watson Health | Life Sciences, Video

Near-real time data access provides integrated views of the patient journey and clinical practice, enabling life sciences organizations to gain deep insights. ...read more


Watson for Drug Discovery Identifies Proteins Associated with Cardiovascular Disease

Written by Watson Health | Blog Post, Drug Discovery, Life Sciences

Heart attack and stroke are 2 of the top 10 causes of death worldwide. Identifying the proteins involved in each of them is the beginning of a journey to understanding how these diseases develop. In a novel experiment presented at the American Heart Association Scientific Sessions on November 12, 2017, and published in a supplement ...read more